Elizabeth Hexner

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Collaborators (8)

Paibel Aguayo-HIraldo

Assistant Professor /Clinical director Transplant and Cellular Therapy

University of Southern California

UNITED STATES

View details

Mitchell E. Hughes

University of Pennsylvania

UNITED STATES

View details

Yu Akahoshi

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Saar I. Gill

University of Pennsylvania

UNITED STATES

View details

Craig Freyer

Hospital of the University of Pennsylvania

UNITED STATES

View details

James Riley

Professor

University of Pennsylvania

UNITED STATES

View details

Stephan Grupp

Section Chief, Cellular Therapy and Transplant

Children's Hospital of Philadelphia

UNITED STATES

View details

Adam Cohen

Associate Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elizabeth Hexner

Research Interests

Explore related searches

Contact this professor

Articles (12)

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD

Evolving racial/ethnic disparities in AML survival in the novel therapy era

Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

The utility of biomarkers in acute GVHD prognostication

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Pemigatinib for the treatment of myeloid/lymphoid neoplasms with <i>FGFR1</i> rearrangement

Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Collaborators (8)

Paibel Aguayo-HIraldo

Mitchell E. Hughes

Yu Akahoshi

Saar I. Gill

Craig Freyer

James Riley

Stephan Grupp

Adam Cohen

Make your next move.